{
  "id": 861589,
  "title": "Barclays downgrades Polypeptide after strong H1 rally, Samsung offer",
  "url": "https://urgent.news/2026/08/14/barclays-downgrades-polypeptide-after-strong-h1-rally-samsung-offer-861589",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-14T10:00:55.000Z",
  "source": {
    "name": "Hellenic Shipping News",
    "slug": "hellenic-shipping-news",
    "url": "https://www.hellenicshippingnews.com/barclays-downgrades-polypeptide-after-strong-h1-rally-samsung-offer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Barclays downgraded Polypeptide Group AG to “equal weight” from “overweight,” citing the stock’s strong year-to-date outperformance, which it said was well justified after the company delivered a high-single-digit percentage sales and underlying EBITDA beat alongside raised full-year guidance in the first half of 2026. The brokerage raised its price target to 44.31 Swiss francs per ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Barclays downgrades Polypeptide after strong H1 rally, Samsung offer",
        "url": "https://urgent.news/2026/08/14/barclays-downgrades-polypeptide-after-strong-h1-rally-samsung-offer",
        "published": "2026-08-14T09:25:19.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}